eHealth (NASDAQ:EHTH) Announces Earnings Results, Misses Estimates By $0.44 EPS

Key Points

• eHealth reported Q1 EPS of ($0.58), missing analysts' estimate of ($0.14) by $0.44, despite beating revenue expectations with $88.0 million and delivering $9 million adjusted EBITDA.
• Management announced targeted cost reductions expected to cut fixed operating costs by ~$30 million in 2026 and is targeting break-even operating cash flow in 2026, break-even free cash flow in 2027 and a path to a 20% adjusted EBITDA margin by 2028 while launching a lifetime advisory model and ancillary products to boost LTV.
• 2026 is an intentional “bridge” year with reduced marketing and lower Medicare volume (Medicare revenue -22%, submissions -24%), a GAAP net loss of $4.7 million and a wide tail revenue guidance of $8M–$20M, creating near-term revenue visibility risk.

eHealth (NASDAQ:EHTH - Get Free Report) announced its quarterly earnings data on Wednesday. The financial services provider reported ($0.58) earnings per share for the quarter, missing analysts' consensus estimates of ($0.14) by ($0.44), FiscalAI reports. eHealth had a return on equity of 5.46% and a net margin of 6.12%.The business had revenue of $88.02 million for the quarter, compared to analyst estimates of $81.21 million.

Here are the key takeaways from eHealth's conference call:

• The company beat internal expectations in Q1 with $88 million revenue and $9 million adjusted EBITDA, driven by stronger-than-expected Medicare enrollment and improved unit economics (MA LTV +3%; acquisition cost per MA approved member -10%).
• Management implemented targeted cost reductions (headcount and vendor consolidation) expected to cut fixed operating costs by ~$30 million in 2026 and is targeting break-even operating cash flow in 2026 and break-even free cash flow in 2027 with a path to 20% adjusted EBITDA margin by 2028.
• eHealth launched a lifetime advisory model, new agent-facing tools, and a final expense insurance product to deepen member relationships and cross-sell ancillaries—management says ancillary sales can meaningfully boost LTV (roughly a ~15–20% uplift per MA sale) and improve retention over time.
• 2026 is an intentional “bridge” year with reduced marketing and lower enrollment volume (Medicare revenue -22%, submissions -24%), GAAP net loss of $4.7 million, and a wide tail revenue guidance range of $8M–$20M, creating near-term revenue visibility risk despite maintained full-year guidance.

eHealth Price Performance

eHealth stock traded up $0.03 during trading hours on Wednesday, hitting $2.00. The stock had a trading volume of 535,034 shares, compared to its average volume of 501,369. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.03 and a quick ratio of 1.03. The stock has a market capitalization of $63.06 million, a price-to-earnings ratio of -2.82 and a beta of 1.57. eHealth has a 1-year low of $1.20 and a 1-year high of $7.09. The stock's fifty day moving average is $1.57 and its two-hundred day moving average is $3.00.

Insiders Place Their Bets

In other news, CFO John Joseph Dolan bought 25,000 shares of the stock in a transaction on Friday, March 6th. The shares were bought at an average price of $1.53 per share, with a total value of $38,250.00. Following the completion of the acquisition, the chief financial officer owned 208,755 shares of the company's stock, valued at approximately $319,395.15. This trade represents a 13.61% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 5.20% of the company's stock.

Institutional Trading of eHealth

Large investors have recently bought and sold shares of the company. The Manufacturers Life Insurance Company acquired a new stake in eHealth in the second quarter valued at $48,000. Bank of America Corp DE grew its holdings in eHealth by 1,265.8% in the second quarter. Bank of America Corp DE now owns 11,186 shares of the financial services provider's stock valued at $49,000 after purchasing an additional 10,367 shares during the last quarter. Alliancebernstein L.P. acquired a new stake in shares of eHealth during the third quarter valued at $54,000. Headlands Technologies LLC acquired a new stake in shares of eHealth during the fourth quarter valued at $62,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new stake in shares of eHealth during the second quarter valued at $68,000. Institutional investors and hedge funds own 79.54% of the company's stock.

Wall Street Analysts Forecast Growth

EHTH has been the topic of a number of recent analyst reports. Zacks Research raised eHealth from a "strong sell" rating to a "hold" rating in a report on Tuesday, April 28th. Craig Hallum lowered eHealth from a "buy" rating to a "hold" rating and set a $2.00 price objective on the stock. in a report on Thursday, February 26th. Finally, Royal Bank Of Canada dropped their price objective on eHealth from $9.00 to $3.00 and set a "sector perform" rating on the stock in a report on Wednesday, March 11th. Four investment analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Reduce" and an average target price of $3.33.

eHealth Company Profile

eHealth, Inc operates one of the largest online private health insurance exchanges in the United States. The company's platform enables consumers to compare, select and enroll in individual, family and small-group health insurance plans offered by a broad network of licensed insurance carriers. In addition to Affordable Care Act–compliant offerings, eHealth provides dedicated services for Medicare Advantage, Medicare Supplement and Medicare Part D prescription drug plans, helping seniors navigate the complexities of Medicare coverage.

Through its digital marketplace, eHealth delivers real-time quotes, detailed plan comparisons and enrollment processing.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.